Homatropine
Systematic (IUPAC) name | |
---|---|
(N-methyl-8-azabicyclo[3.2.1]oct-3-yl) 2-hydroxy-2-phenylacetate | |
Clinical data | |
AHFS/Drugs.com | monograph |
MedlinePlus | a601006 |
Legal status | ? |
Identifiers | |
CAS number | 87-00-3 |
ATC code | A02BX03 S01FA05 |
PubChem | CID 6321423 |
DrugBank | DB00725 |
ChemSpider | 16498795 |
UNII | 8QS6WCL55Z |
ChEMBL | CHEMBL1233442 |
Chemical data | |
Formula | C16H21NO3 |
Mol. mass | 356.26 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Homatropine (Equipin, Isopto Homatropine) is an anticholinergic medication that is an antagonist at muscarinic acetylcholine receptors and thus the parasympathetic nervous system. It is used in eye drops as a cycloplegic (to temporarily paralyze accommodation), and as a mydriatic (to dilate the pupil). For Homatropine methylbromide see Methylhomatropine, this is a different medication. Homatropine is less potent than atropine and has a shorter duration of action. It is available as the hydrobromide salt.
Homatropine is also given as an atropine substitute given to reverse the muscarinic and CNS effects associated with indirect cholinomimetic (anti-AChase) administration.
Side effects
- Blurred vision
- Sensitivity to light
Complications
- Untreated glaucoma
- Myasthenia gravis
- Severe heart failure
- Thyrotoxicosis
References
|